BIOARCTIC
LIVE

Serial Number

79309164

Owner

BioArctic AB

Attorney

Jessica S. Sachs

Filing Date

Dec 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BIOARCTIC Trademark

Serial Number: 79309164 • Registration: 6749255

BIOARCTIC is a trademark filed by BioArctic AB on December 14, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

BioArctic AB (3 trademarks)

Warfvinges väg 35
Stockholm 11251 , SE

Entity Type: 99

Trademark Details

Filing Date

December 14, 2020

Registration Date

June 7, 2022

Published for Opposition

February 15, 2022

Goods & Services

Scientific and technological services, namely, scientific research and product development and design, in the field of neurodegenerative disorders; medical and pharmacological research services; medical, pharmaceutical and biotechnological laboratory research services; scientific investigations for medical purposes; medical and scientific services, namely medical and scientific research services in the field of the central nervous system, brain disorders and central nervous system related disorders, diseases and pharmaceuticals; medical and scientific research in the field of neurological and neurodegenerative diseases; conducting clinical trials for others; providing scientific information about the results of clinical trials for pharmaceutical products; biochemical analysis and research; drug discovery services; pharmaceutical products development and evaluation

Medical and veterinary preparations for the treatment of neurodegenerative disorders; medical and veterinary articles, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; pharmaceutical preparations and substances for the treatment of neurodegenerative disorders; biochemical preparations for medical use for the treatment of neurodegenerative disorders; pharmaceutical preparations and medical preparations for the treatment, prevention and diagnosis of Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases and disorders of the central nervous system; antibodies and antibodies-based pharmaceutical preparations for medical purposes; diagnostic preparations for medical or veterinary purposes; medical therapeutic agents for neurodegenerative disorders; reagents for medical use; diagnostic biochemical biomarker reagents for medical use; diagnostic biomarker reagents for medical purposes; live organs and tissues for surgical implantation purpose; cells for medical use; stem cells for medical purposes; sanitary preparations for medical purposes; dietetic substances, namely, dietetic foods adapted for medical purposes; diagnostic materials, namely, diagnostic kits consisting primarily of probes, buffers, and reagents for use in testing for neurological disorders and central nervous system disorders

Chemical substances, chemical materials, chemical preparations, and non-synthetic elements for use in the manufacture of pharmaceuticals; chemical substances and materials for industrial, scientific and laboratory use, other than for medical or veterinary purposes; biochemical preparations for scientific purposes for use in the manufacture of pharmaceuticals; chemical substances for use in the production of drugs, pharmaceuticals and antibodies; reagents for scientific, laboratory, analysis, research, medical research, testing, inspection, detecting or verification use, other than for medical purposes; reagents for scientific or medical research use for use in the development of antibodies, other than for medical or veterinary purposes; reagents for scientific or medical research use for use in scientific apparatus for chemical or biological analysis; stem cells and reconstituted cells for research or scientific purposes; reconstituted cells for the efficiency and tolerance testing of pharmaceutical products for research or scientific purposes; antibodies and antibodies-based chemicals, for use in industry and science, except for medical or veterinary use; biological preparation for use in cell cultures other than for medical or veterinary use; all of the foregoing for use in the manufacture of pharmaceuticals

Legal services; licensing of research and development methods; licensing of intellectual property

Human healthcare services; medical services; providing medical information; physical examination services; rental of medical machines and apparatus; providing information relating to the rental of medical machines and apparatus; medical diagnostic testing services; optical imaging for medical diagnostic use being medical imaging services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposes

Medical and veterinary apparatus and instruments, namely, syringes for medical purposes, syringes for injections, hypodermic syringes; medical imaging apparatus; medical apparatus and devices for the diagnosis and treatment of neurological disorders and central nervous system disorders

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 10, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 16, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 16, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 7, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 7, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 7, 2022 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 17, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 17, 2022 ECDR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 17, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 17, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 17, 2022 REAP
ELECTRONIC RECORD REVIEW COMPLETE
Apr 29, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 1, 2022 ERRR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 15, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Feb 14, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 26, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 26, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 26, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 11, 2022 PREV
ASSIGNED TO LIE
Jan 11, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 10, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 10, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 10, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 10, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 13, 2021 TROA
REFUSAL PROCESSED BY IB
Jul 5, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 11, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 11, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 8, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 7, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 7, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 27, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 23, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 22, 2021 REPR